No Data
Percheron Therapeutics Price Target Cut 7% to A$0.25/Share by Wilsons
Percheron Therapeutics to Raise AU$13 Million via Share Placement; Shares Slump 35%
Percheron Therapeutics Ltd: Percheron Receives $2.35 million R&D Tax Incentive Rebate
Percheron Therapeutics Validates Effectivity of Autoimmune Epilepsy Medication in Animal Study
Percheron Therapeutics Ltd: Appendix 4E and Annual Report
Investing in Percheron Therapeutics (ASX:PER) Five Years Ago Would Have Delivered You a 67% Gain
No Data
No Data